1. Israel Stocks

  2. •

    Distribution services

  3. •

    Medical distributors
Novolog (Pharm UP 1966) Ltd.

Novolog (Pharm UP 1966) Ltd.

TTASE:NVLG
88.20
ILA
-0.40
(-0.45%)
-0.12EPS
38.21BMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
1.95
2.11
2.4
2.6
2.6
2.45
2.48
2.97
3.22
3.96
3.53
3.55
Basic EPS, GAAP
0.07
0.08
0.07
0.06
0.03
0.09
0.08
0.09
-0.08
0.08
0.01
- -
Free Cash Flow per Basic Share
0.37
0.02
0.15
-0.02
0.2
0.07
0.1
0.12
0.25
0.2
-0.12
0.07
Dividend per Share
0.05
0.14
0.05
0.02
0.04
0.03
0.06
0.06
0.03
0.08
0.04
0.04
Book Value per Share
- -
0.2
0.24
0.3
0.57
0.64
0.92
0.94
0.73
0.72
0.7
0.69
Tangible Book Value per Share
- -
0.07
-0.01
0.01
0.11
0.16
0.36
0.23
0.14
0.1
0.06
0.04
Basic Weighted Avg Shares
350
350
350
350
387
464
505
507
510
511
511
511
Sales/Revenue/Turnover
683
739
839
910
1,004
1,134
1,255
1,508
1,643
2,022
1,805
1,815
Operating Margin (%)
5.35
5.48
3.25
3.35
3.49
4.83
5.41
5.16
3.07
3.46
1.46
1.81
Depreciation Expense
9
11
14
20
44
44
46
53
116
79
86
79
Net Income, GAAP
25
29
23
23
10
40
42
48
-42
40
4
-1
Effective Tax Rate (%)
27.21
24.86
23.11
28.19
44.79
22.77
24.78
23.42
605.43
28.71
41.9
403.19
Profit Margin (%)
3.7
3.94
2.76
2.48
1.01
3.53
3.37
3.15
-2.56
1.96
0.23
-0.04
Working Capital
- -
-19
-68
-64
-38
-26
53
-36
-78
-93
-119
-128
LT Debt
- -
- -
3
1
142
138
146
190
188
177
158
154
Total Equity
- -
71
86
107
264
296
430
464
396
382
369
357
Return on Invested Capital (%)
- -
- -
30.54
26.2
6.9
10.8
10
9.33
-2.07
7.45
1.81
-17.84
Return on Capital (%)
- -
- -
29.28
23.27
5.45
10.39
8.82
8.43
-17.02
7.9
2.64
-13.8
Return on Common Equity (%)
- -
- -
29.64
23.46
5.48
14.35
11.77
11.05
-10.41
10.69
1.13
-0.19

Capital Structure

ILS

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
25
21
17
LT Borrowings
- -
- -
- -
LT Finance Leases
158
155
154
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
511
511
511
Market Capitalization
642
511
382

Working Capital

ILS

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,493
1,792
2,057
Cash, Cash Equivalents & STI
122
163
204
Accounts Receivable, Net
1,012
1,240
1,501
Inventories
251
280
294
Total Current Liabilities
1,612
1,911
2,185
Payables & Accruals
- -
- -
- -
ST Debt
25
21
17
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.35%
-3.46%
Free Cash Flow
-116.35%
-0.31%
-163.42%
Net Income, GAAP
-22.19%
-90.85%
-89.59%
Sales/Revenue/Turnover
10.55%
10.43%
-10.7%
Total Cash Common Dividend
35.36%
41.21%
-50%

Quarterly Revenue

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
454
477
551
690
2,022
2025
507
442
484
373
1,805
2026
506
452
- -
- -
- -

Quarterly Earnings Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.02
0.03
0.02
- -
0.08
2025
- -
0.01
0.01
-0.01
0.01
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.03
0.03
0.02
0.08
2025
- -
- -
0.02
0.02
0.04
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Eran Taus
Full Time Employees
916
Sector
Distribution services
Industry
Medical distributors
Address
55 Ma'ayan Street Modi'in-Maccabim-Re'ut HM Israel 7171301
IPO Date
Feb 28, 2017
Website
novolog.co.il
Similar Companies
DataMeds AI, Inc. (NASDAQ:MEDS)
Selcuk Ecza Deposu Ticaret ve Sanayi A.S. (BIST:SELEC)
McKesson Corporation (NYSE:MCK)
Ibnsina Pharma (EGX:ISPH)
Cardinal Health, Inc. (NYSE:CAH)
Entero Healthcare Solutions Limited (NSE:ENTERO)
Business
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel through three main divisions: Logistics, Health Services, and Digital. The Logistics division handles import and distribution of medicines and medical products to pharmacies, hospitals, and patients; logistics for clinical trials and related services including Trialog-Clinical Trial Logistics; pharmaceutical services to customers; and sterilization and validation processes for consumable medical equipment using ethylene oxide gas. The Health Services division offers in-home nursing and patient care through subsidiaries such as Care for Life-Professional Nurses Service; customized medicine, medical and diagnostic laboratory services via acquisitions like American Medical Laboratories (75% stake for ILS 21 million), Pronto Diagnostics (75% stake for ILS 11 million), and Gsap Biomed (60% stake for ILS 33 million); and health process management for corporations, insurance companies, health organizations, and government bodies. The Digital division develops technological tools and platforms for health services; disseminates medical content to the public and professionals; promotes digital presence for clinics, doctors, and therapists; and provides telemedicine, appointment scheduling, and management tools including the Symptomi platform launched with startup Kahun for preliminary medical inquiries. Founded in 1966 and headquartered at 55 Maayan Street in Modi'in, Israel, the company employs over 900 people and serves all public and private medical entities nationwide as well as international pharmaceutical and medical device firms. Recently, Novolog implemented a new ERP system; appointed Aviad Busi as group CEO following Eran Taus's resignation in 2023; distributed multiple dividends totaling over ILS 50 million in 2024 including NIS 10 million in November and NIS 15 million in August; reported third-quarter and nine-month earnings for 2025; and continued expansion through prior acquisitions while listing on the Tel Aviv 125 Index.